Agouron Pharmaceuticals Inc.

Immune Response Cuts Staff To Focus On Remune; CEO Resigns.
BIOWORLD Today; 11/4/2009; 1387 words; ...completed in Spain was originally thought to be a failure, and in July 2001, Immune Response's Remune partner, Agouron Pharmaceuticals Inc., returned rights to the vaccine. But an analysis done by an independent Data Safety Monitoring Board found...

CV Therapeutics Regains Full Ranexa Rights From Innovex.
BIOWORLD Today; 11/4/2009; 1281 words; ...preferred provider of pharmaceutical services for CV Therapeutics...from Needham & Co. Inc. and Deutsche Bank...prior employment at Agouron Pharmaceuticals Inc., of San Diego...He helped launch Agouron's Viracept, a protease...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2303 words; ...on cancer and infectious diseases. o Agouron Pharmaceuticals Inc., of La Jolla. Calif., a unit of Pfizer Inc., reported data at the International...in Toronto. o Amylin Pharmaceuticals Inc., of San Diego, was added to the Russell...

NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer.
Biotech Week; 11/4/2009; 701 words; NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY...the company (see also Pharmaceuticals). "We are adding Mark...Pharmaceuticals, Pfizer-Agouron and Ligand-Glycomed...NovaBay Pharmaceuticals Inc. This article was prepared...

YM Gaining Subsidiary Via Eximias Acquisition.
BIOWORLD Today; 11/3/2009; 1131 words; ...to purchase Eximias Pharmaceutical Corp. in a cash and...as YM BioSciences USA Inc., with Schulze staying...under the name Zarix Inc., Eximias licensed...Jolla, Calif.-based Agouron Pharmaceuticals Inc. But development hit...